Featured Research

from universities, journals, and other organizations

Researchers devise index for predicting long-term survival after liver re-transplantation

Date:
September 29, 2011
Source:
University of California - Los Angeles Health Sciences
Summary:
Researchers have identified eight risk factors for potential re-transplantation failure and, using mathematical modeling, developed a risk scoring system ranging from 0 to 12 to gauge the risk of re-transplantation failure.

Liver re-transplantation generally has an inferior outcome compared with a patient's first transplant, due to the technical demands of the surgery and because patients are often sicker than they were at the time of their first procedure.

UCLA researchers, basing their work on 26 years worth of patient data from UCLA, sought to develop a scoring system for risk stratification of patients in need of a liver re-transplant, in the hopes of improving patient selection for scarce livers.

They identified eight risk factors for potential re-transplantation failure and, using mathematical modeling, developed a risk scoring system ranging from 0 to 12 to gauge the risk of re-transplantation failure.

The predictive index can help guide physicians in determining the potential risk to patients of liver re-transplantation and can provide patients with risk/benefit information during the informed consent process.

Study authors are Johnny C. Hong, Fady M. Kaldas, Prawat Kositamongkol, Henrik Petrowsky, Douglas G. Farmer, Daniela Markovic, Jonathan R. Hiatt and Ronald W. Busuttil, all of UCLA.

The research is published in the September issue of the journal Annals of Surgery.


Story Source:

The above story is based on materials provided by University of California - Los Angeles Health Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. Johnny C. Hong, Fady M. Kaldas, Prawat Kositamongkol, Henrik Petrowsky, Douglas G. Farmer, Daniela Markovic, Jonathan R. Hiatt, Ronald W. Busuttil. Predictive Index for Long-Term Survival After Retransplantation of the Liver in Adult Recipients. Annals of Surgery, 2011; DOI: 10.1097/SLA.0b013e31822c5878

Cite This Page:

University of California - Los Angeles Health Sciences. "Researchers devise index for predicting long-term survival after liver re-transplantation." ScienceDaily. ScienceDaily, 29 September 2011. <www.sciencedaily.com/releases/2011/09/110929103226.htm>.
University of California - Los Angeles Health Sciences. (2011, September 29). Researchers devise index for predicting long-term survival after liver re-transplantation. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2011/09/110929103226.htm
University of California - Los Angeles Health Sciences. "Researchers devise index for predicting long-term survival after liver re-transplantation." ScienceDaily. www.sciencedaily.com/releases/2011/09/110929103226.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins